Demographic disparities in oncology clinical trial participation persist; while research staff perform key research functions, there are few data regarding whether training programs improve their knowledge of trial-related enrollment disparities.
We evaluated the impact of an oncology research staff traini...
Kristen A. Legor, Cameron Keith, Emerald Littlejohn et al.· Cancer Epidemiology, Biomark...· 0 citations
The combination of azenosertib and gemcitabine was associated with substantial myelosuppression in patients with metastatic PDAC previously treated with FOLFIRINOX, limiting further clinical evaluation of this dosing strategy.
B. Huffman, Haeseong Park, N. Jackson et al.· Cancer Research· 0 citations
A proof-of-concept study that demonstrates the feasibility of leveraging ePROs linked with EHR data to identify adults with cancer experiencing fertility concerns and characterize subsequent oncofertility care and inform interventions to improve fertility counseling, referral, and navigation for adults with cancer.
Nadine A. Jackson, B. A. Neville, J. Stal et al.· JCO Oncology Practice· 0 citations
High-dose vitamin D3 added to standard treatment improved progression-free survival (PFS) compared to standard-dose vitamin D3 in patients with metastatic colorectal cancer (mCRC) in a phase 2 randomized clinical trial.
K. Ng, F. Ou, T. Zemla et al.· Journal of the American Medi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.